Publications by authors named "Mark Malamood"

Introduction: Gastroparesis symptoms can be severe and debilitating. Many patients do not respond to currently available treatments. Mirtazapine has been shown in case reports to reduce symptoms in gastroparesis.

View Article and Find Full Text PDF

A 24-year-old man with sickle cell anemia presented with fatigue, dark stool, and coffee ground emesis. He was found to have large esophageal varices and experienced massive variceal hemorrhage in the hospital. The varices were caused by diffuse splanchnic venous thrombosis, and his only risk factor for hypercoagulability was sickle cell anemia.

View Article and Find Full Text PDF

Introduction: Gastroparesis is a syndrome defined by delayed gastric emptying in the absence of mechanical obstruction. Gastroparesis has significant symptomatology and negative impacts on the patient's quality of life.

Areas Covered: This article reviews current treatment options for gastroparesis, recent advances in treatment and future directions that treatment may head.

View Article and Find Full Text PDF

Background: For severe, complicated Clostridium difficile infection (CDI), concomitant treatment with IV metronidazole and oral vancomycin is usually prescribed. Sometimes vancomycin per rectum (VPR) is added to increase colonic drug delivery. Our purpose was to examine clinical outcomes of patients with CDI treated with VPR and compare results to a matched control group.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Mark Malamood"

  • - Mark Malamood's research primarily focuses on gastrointestinal disorders, particularly gastroparesis, exploring innovative treatment options and their efficacy.
  • - He has investigated the effectiveness of mirtazapine for symptom control in refractory gastroparesis, as well as reviewed current and future treatment advancements for this condition.
  • - Additionally, Malamood has contributed to understanding rare complications in systemic diseases, such as massive esophageal variceal bleeding in sickle cell anemia and the use of vancomycin enemas for treating Clostridium difficile infections.